Don't miss Dr. Soo Park at tomorrow's #ASCO25 poster session on melanoma and skin cancers! 💡 Dr. Park will be presenting early results from a study showing cemiplimab's effects in real world patients. 🔗 Learn more about this session: meetings.asco.org/2025-asco-annu…

Moores member Kathryn Ries Tringale will be sharing the latest insights into deep learning-based MRI therapeutics at #ASCO25 🔬 Join us at 11:15 a.m. for her presentation during a rapid oral abstract session focusing on developmental therapeutics! 🔗 Learn more about the session:

Don't miss Jona Hattangadi-Gluth, MD's presentation on artificial intelligence-enhanced radiation oncology! 💡🤖 Join Dr. Hattangadi-Gluth at 11:30 a.m. to learn more about recent research findings on AI usage in brain tumor treatment. 🔗 Add to your #ASCO25 agenda: meetings.asco.org/2025-asco-annu…

Join Dr. Sharon H. Choi at 9:00 a.m. tomorrow for "Comprehensive Genomic Profiling of Black and Non-Hispanic White Men with Prostate Cancer" 🧬 Dr. Choi's #ASCO25 poster highlights key insights into racial differences in tumor biology and advancing equity in prostate cancer

Join Rana McKay, MD, FASCO at 9:00 a.m. tomorrow for "Molecular and Clinical Characterization of KLK2 mRNA Expression in Prostate Cancer" 🧬 Dr. McKay will present new data exploring KLK2 as a potential biomarker in prostate cancer. Don’t miss this poster session on advancing precision

Don’t miss Rana McKay, MD, FASCO presenting new research from the PREDICT trial — a Phase 2, biomarker-driven study shaping the future of precision prostate cancer care. 🩺 Join us tomorrow from 9:00 a.m. to 12:00 p.m. to learn more about this groundbreaking research! 🔗 Add to your

Join Dr. Yu-Wei Chen at 9:00 a.m. tomorrow for "HIF Family Transcription Factor Expression in Renal Cell Carcinoma" 🔬 Dr. Chen will be presenting at an #ASCO25 session focused on advancements in kidney and bladder cancers. 🔗 Learn more about this session:

Join DrBagrodia at 1:15 p.m. today for "Contemporary Management of Stage II Seminoma" 🎯 Dr. Bagrodia will be chairing this session on refining treatment strategies for metastatic germ-cell tumors—what’s changing, and what’s next for this disease. 🔗 Add to your #ASCO25

Excited to present our #ASCO25 poster on the RADICAL trial! 🎯 📌 Radium-223 + Cabozantinib vs Cabozantinib in RCC with bone mets 🎯 SSE-free survival, PFS, OS, QOL, liquid + tissue biomarkers 🧪 Trial OPEN for accrual! Thanks to Rana McKay, MD, FASCO for your mentorship and

MCC's Erik Bergstrom, PhD, & Ludmil Alexandrov, PhD, developed #DeepHRD, an AI tool that quickly detects DNA repair defects in breast & ovarian cancers from biopsy images. Discover how this speeds diagnosis & helps tailor treatments faster than traditional genetic tests:

Tomorrow at #ASCO25, join Dr. Jyoti Mayadev for the latest in gynecologic cancer research 🔬 Dr. Mayadev will be presenting trial results showing how ctDNA levels correlate with relapse and survival, advancing personalized strategies for treating cervical cancer. 🔗 Learn more

MCC's Rana McKay, MD, FASCO will present early efficacy data from a trial exploring new treatment combinations for CRPC today at #ASCO25! 🌟 Join us at 9:45 a.m. to learn more about the COMRADE Trial, and how these findings will impact treatment of castration-resistant prostate cancer.

Meet Gene Yeo, PhD (Gene Yeo’s Lab at UC San Diego) — MCC's new Associate Director of Translational Science, in this #ResearcherSpotlight. A prominent leader across UC San Diego, Dr. Yeo shares his vision for this role, ongoing projects in his lab & where he sees his research heading over the next

Tune in to the latest episode of #TheScienceof Podcast as we explore the science of #CancerImmunology in triple negative breast cancer with Dr. Asona Lui of the UC San Diego Health Moores Cancer Center Radiation and Oncology Department and the students of the YMCA. Listen Here:shorturl.at/SvbZU

Honored to join the Board of Governors for Biocom California alongside such accomplished leaders in science & biotechnology. Excited to amplify the voices of academic cancer centers such as UC San Diego Health Moores Cancer Center & accelerate innovation that directly benefits patients! bit.ly/4kU4t4j

Had a rewarding fireside chat with Ambry Genetics CEO Tom Schoenherr after giving an address on germline genetics & cancer. Our goal: better identify who’s at risk and drive earlier detection. Grateful for partnerships fueling the future of precision medicine. #PrecisionMedicine

📢🔖Check out the insights of our brilliant UC San Diego Health Moores Cancer Center colleague Dr. Josh Demb in this important article from @businessinsider: "The taboo #ColonCancer symptom millennials are afraid to tell their doctors about" businessinsider.com/rectal-bleedin… #CRCSM #GetScreened

MCC's Alexis C. Komor, PhD — a pioneer in base editing — led a study showing how certain DNA repair proteins can influence the accuracy of gene-editing tools. By identifying which proteins interfere with or support precise edits, her team is helping make gene editing safer and

Meet Dr. Haydee Ojeda-Fournier in this edition of the #ResearcherSpotlight! She shares what it means to be named the inaugural Grillo-Marxuach Family Endowed Medical Director in Breast Imaging and highlights her recent work as a clinician-scientist: bit.ly/3XDvbFm.